Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,952 | 9,210 | 22,962 | 21,091 | 38,388 |
| Marketable Securities | 14,737 | 21,934 | 26,583 | 64,028 | 33,759 |
| Receivables | 2,039 | 100 | N/A | N/A | N/A |
| TOTAL | $35,531 | $31,925 | $50,803 | $86,985 | $74,768 |
| Non-Current Assets | |||||
| PPE Net | 899 | 1,270 | 1,853 | 2,280 | 1,421 |
| Investments And Advances | 0 | 0 | 0 | 0 | 4,002 |
| Other Non-Current Assets | 2,296 | 2,993 | 90 | 90 | 333 |
| TOTAL | $3,195 | $4,263 | $1,943 | $2,370 | $5,756 |
| Total Assets | $38,726 | $36,188 | $52,746 | $89,355 | $80,524 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 7,767 | 5,012 | 339 |
| Accounts payable and accrued liabilities | 1,431 | 847 | 1,040 | 2,276 | 2,606 |
| Accrued Expenses | 3,572 | 2,376 | 2,026 | 3,103 | 5,450 |
| Other current liabilities | N/A | 208 | N/A | N/A | N/A |
| TOTAL | $5,864 | $12,923 | $10,833 | $10,391 | $8,525 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 8,263 | 14,719 | 9,198 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 130 |
| Other Non-Current Liabilities | 1,384 | 2,399 | 0 | 0 | 0 |
| TOTAL | $1,378 | $2,239 | $8,263 | $14,719 | $9,198 |
| Total Liabilities | $7,242 | $15,162 | $19,096 | $25,110 | $17,723 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,011 | 9,352 | 2,482 | 2,128 | 1,696 |
| Common Shares | 11 | 4 | 2 | 30 | 24 |
| Retained earnings | -338,528 | -322,304 | -298,701 | -264,186 | -215,979 |
| Other shareholders' equity | -209 | -200 | -60 | -120 | -76 |
| TOTAL | $31,484 | $21,026 | $33,650 | $64,245 | $62,801 |
| Total Liabilities And Equity | $38,726 | $36,188 | $52,746 | $89,355 | $80,524 |